Literature DB >> 11464288

Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.

H Xi1, B Goodwin, A T Shepherd, G Blanck.   

Abstract

Class II transactivator (CIITA) is required for both constitutive and inducible expression of MHC class II genes. IFN-gamma induced expression of CIITA in various cell types is directed by CIITA type IV promoter. The two transactivators, STAT1 and IRF-1, mediate the IFN-gamma activation of the type IV promoter by binding to the GAS and IRF-E of the promoter, respectively. In addition to IRF-1, IRF-2, another member of the IRF family, also activates the human CIITA type IV promoter, and IRF-2 cooperates with IRF-1 to activate the promoter in transient transfection assays. IRF-1 and IRF-2 can co-occupy the IRF-E of the human CIITA type IV promoter. To understand the effect of loss of IRF-2 on the endogenous CIITA expression, we assayed for CIITA expression in IRF-2 knock-out mice. Both basal and IFN-gamma induced CIITA expression were reduced in IRF-2 knock-out mice. At least half of the amount of inducible CIITA mRNA depends on IRF-2. The reduction of IFN-gamma induced CIITA mRNA in IRF-2 knock-out mice was due to the reduction of the type IV CIITA mRNA induction. The reduction of basal CIITA mRNA was apparently due to the reduction of CIITA mRNA originating from other promoters. These data indicate that IRF-2, like IRF-1, plays a critical role in the regulation of the endogenous CIITA gene. The implications in understanding the previously described phenotypes of IRF-2 defective mice are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11464288     DOI: 10.1038/sj.onc.1204556

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells.

Authors:  Kenya Honda; Tatsuaki Mizutani; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

3.  MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor development.

Authors:  John M Yavorski; George Blanck
Journal:  Mol Clin Oncol       Date:  2017-09-29

4.  Apical role for BRG1 in cytokine-induced promoter assembly.

Authors:  Zuyao Ni; Elizabeth Karaskov; Tao Yu; Steven M Callaghan; Sandy Der; David S Park; Zhaodong Xu; Samantha G Pattenden; Rod Bremner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-29       Impact factor: 11.205

5.  Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent.

Authors:  Samantha G Pattenden; Robert Klose; Elizabeth Karaskov; Rod Bremner
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

6.  Regulation of CEACAM1 transcription in human breast epithelial cells.

Authors:  Marieta Gencheva; Charng-Jui Chen; Tung Nguyen; John E Shively
Journal:  BMC Mol Biol       Date:  2010-11-04       Impact factor: 2.946

7.  Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells.

Authors:  Shigeru Oshima; Tetsuya Nakamura; Shin Namiki; Eriko Okada; Kiichiro Tsuchiya; Ryuichi Okamoto; Motomi Yamazaki; Takanori Yokota; Masatoshi Aida; Yuki Yamaguchi; Takanori Kanai; Hiroshi Handa; Mamoru Watanabe
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

8.  Identification of novel co-repressor molecules for Interferon Regulatory Factor-2.

Authors:  Kay S Childs; Stephen Goodbourn
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

Review 9.  Regulation of major histocompatibility complex class II gene expression in trophoblast cells.

Authors:  Shawn P Murphy; Jason C Choi; Renae Holtz
Journal:  Reprod Biol Endocrinol       Date:  2004-07-05       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.